Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
With Cold Weather quickly approaching, The Food and Drug Administration finally approved FluMist to be used at Home.
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
The vaccine, called FluMist, is a nasal vaccine that's been available since 2003 but given in-clinic by a healthcare provider ...
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...